Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Like any medication, weight-loss injections can have side effects
Various factors can affect the level of carnitine in vivo
Neurogastroenterol Motil (2014) 26:115562
Producer UL CORPORATION CO., LTD
Brand name Active drug Indication Approval year Max approved dose Ozempic Semaglutide Type 2 diabetes (glycemic control) 2017 2 mg/week Wegovy Semaglutide Chronic weight management (BMI 30 or 27 + comorbidity) 2021 2.4 mg/week Rybelsus Semaglutide Type 2 diabetes (oral daily tablet) 2019 14 mg/day (oral) Mounjaro Tirzepatide Type 2 diabetes (glycemic control) 2022 15 mg/week Zepbound Tirzepatide Chronic weight management (BMI 30 or 27 + comorbidity) 2023 15 mg/week Table 1 FDA-approved indications for semaglutide and tirzepatide brand names
US$ 20.93
US$ 22.90
US$ 24.97
US$ 22.87
US$ 22.95
